Sixty-five percent of dermatology providers surveyed agree there is a lack of education and understanding of chronic hand ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year, putting the company on track to meet its ...

MADISON, N.J.--(BUSINESS WIRE)--Sixty-five ... (AD), according to the first phase of the survey commissioned by LEO Pharma Inc., a global leader in medical dermatology, and conducted by Ipsos.

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83rd American Academy ...

BALLERUP, Denmark, February 26, 2025--(BUSINESS WIRE)--LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook ...

BALLERUP, Denmark, February 26, 2025--(BUSINESS WIRE)--LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for ...